Detalhe da pesquisa
1.
The MUC1-HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling.
Proc Natl Acad Sci U S A
; 121(14): e2315509121, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547055
2.
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.
Gastroenterology
; 161(5): 1584-1600, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245764
3.
Insights into gemcitabine resistance and the potential for therapeutic monitoring.
Metabolomics
; 14(12): 156, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30830412
4.
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells.
J Proteome Res
; 16(10): 3536-3546, 2017 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28809118
5.
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer.
Proc Natl Acad Sci U S A
; 109(34): 13787-92, 2012 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22869720
6.
Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells.
Cancer Discov
; 14(1): 176-193, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931287
7.
Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis.
Nat Cell Biol
; 26(4): 613-627, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429478
8.
ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer.
Cancer Lett
; 552: 215981, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36341997
9.
CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis.
Oncogene
; 41(7): 971-982, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35001076
10.
Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.
Nat Med
; 26(6): 982, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483362
11.
SIRT1-NOX4 signaling axis regulates cancer cachexia.
J Exp Med
; 217(7)2020 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441762
12.
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.
Nat Med
; 25(4): 628-640, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30833752
13.
Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis.
Nat Cell Biol
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38641662
14.
The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis.
Mol Cell Biol
; 25(17): 7592-604, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16107706
15.
Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
PLoS One
; 12(6): e0179098, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28570622
16.
MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
PLoS One
; 12(5): e0176820, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464016
17.
MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.
Clin Cancer Res
; 23(19): 5881-5891, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28720669
18.
De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.
Cancer Res
; 77(20): 5503-5517, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28811332
19.
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Cancer Cell
; 32(1): 71-87.e7, 2017 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28697344
20.
Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
Oncotarget
; 6(38): 41146-61, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510913